Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-31 @ 3:21 AM
Study NCT ID:
NCT07419633
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-19
First Post:
2026-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.
Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-02-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-05
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-21
First Submit QC Date:
None
Study First Post Date:
2026-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-16
Last Update Post Date:
2026-02-19
Last Update Post Date Type:
ACTUAL